Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeted cancer stem cell therapies start with proper identification of the target.

× No keyword cloud information.

3 in total

1. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Authors: Xing Fan; Leila Khaki; Thant S Zhu; Mary E Soules; Caroline E Talsma; Naheed Gul; Cheryl Koh; Jiangyang Zhang; Yue-Ming Li; Jarek Maciaczyk; Guido Nikkhah; Francesco Dimeco; Sara Piccirillo; Angelo L Vescovi; Charles G Eberhart
Journal: Stem Cells Date: 2010-01 Impact factor: 6.277

2. z-Leucinyl-leucinyl-norleucinal induces apoptosis of human glioblastoma tumor-initiating cells by proteasome inhibition and mitotic arrest response.

Authors: Massimiliano Monticone; Emanuela Biollo; Andrea Fabiano; Marina Fabbi; Antonio Daga; Francesco Romeo; Massimo Maffei; Alice Melotti; Walter Giaretti; Giorgio Corte; Patrizio Castagnola
Journal: Mol Cancer Res Date: 2009-10-27 Impact factor: 5.852

3. In vivo imaging, tracking, and targeting of cancer stem cells.

Authors: Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal: J Natl Cancer Inst Date: 2009-02-24 Impact factor: 13.506

3 in total

5 in total

Review 1. Opportunities and challenges of radiotherapy for treating cancer.

Authors: Dörthe Schaue; William H McBride
Journal: Nat Rev Clin Oncol Date: 2015-06-30 Impact factor: 66.675

2. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.

Authors: Daniela A Bota; Daniela Alexandru; Stephen T Keir; Darell Bigner; James Vredenburgh; Henry S Friedman
Journal: J Neurosurg Date: 2013-10-04 Impact factor: 5.115

3. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.

Authors: Jianjun Zhou; Honghe Wang; Virginetta Cannon; Karen Marie Wolcott; Hongbin Song; Clayton Yates
Journal: Mol Cancer Date: 2011-09-14 Impact factor: 27.401

4. Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway.

Authors: Yi Zhang; Hai-xuan Chen; Shu-yan Zhou; Shao-xiang Wang; Kai Zheng; Dan-dan Xu; Yu-ting Liu; Xiao-yan Wang; Xiao Wang; Hai-Zhao Yan; Li Zhang; Qiu-ying Liu; Wan-qun Chen; Yi-fei Wang
Journal: Mol Cancer Date: 2015-03-07 Impact factor: 27.401

5. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling.

Authors: Lishan Fang; Junchao Cai; Baixue Chen; Shanshan Wu; Rong Li; Xiaonan Xu; Yi Yang; Hongyu Guan; Xun Zhu; Le Zhang; Jie Yuan; Jueheng Wu; Mengfeng Li
Journal: Nat Commun Date: 2015-10-15 Impact factor: 14.919

5 in total